Jump to content

Drilldown: Medicines

Choose a table:


Medicines > generic : 1P-LSD or 2C-B or Linagliptin

Use the filters below to narrow your results.

generic: (Click arrow to add another value)
brand:
None (1) · Nexus, Eroxan (historical, late-1980s through mid-1990s) (1) · Tradjenta; with metformin Jentadueto (1)
classes:
2C-x series (1) · Classic Psychedelic (1) · Lysergamide (1) · Phenethylamine (1) · Psychedelic (1) · Research material (1) · [[:Category:Antihyperglycemic_agents|Antihyperglycemic agent]] (1) · [[:Category:DPP-4_inhibitors|DPP-4 inhibitor]] (1) · [[:Category:Incretin_modulators|Incretin pathway modulator]] (1)
mechanism:
None (1) · 5-HT2A partial agonist (1) · Prodrug of LSD; 5-HT2A agonist (1)
uses:
None (2) · '"`UNIQ--vote-0000117B-QINU`"' (1)
starting dose:
None (2) · 5 mg PO once daily (no renal dose adjustment, unlike sitagliptin) (1)
preparations:
None (2) · 5 mg tablets; combination with metformin (1)
fda max:
None (2) · 5 mg/d (1)
routes:
None (1) · insufflated (1) · Oral (2) · PR (1)
onset:
None (1) · 45-75 min (oral) (1) · Postprandial glucose effect within days; HbA1c by 12 weeks (1)
duration:
None (1) · 24 hours (1) · 4-8 h (1)
halflife:
None (1) · Not well characterized (1) · ~12 hours (effective); terminal much longer'"`UNIQ--ref-0000117C-QINU`"' (1)
bioavailability:
None (1) · Not well characterized (1) · ~30% (oral)'"`UNIQ--ref-0000117D-QINU`"' (1)
pregnancy:
None (1) · Limited data; switch to insulin where feasible.<sup class="pcp-cn" title="This claim needs a citation.">&#91;[[Pharmacopedia:Citation needed|citation&nbsp;needed]]&#93;</sup> (1) · Not established (1)
legal:
None (1) · [[USLegal:DEA Schedule I|Schedule I]] (United States) (1) · [[USLegal:Prescription only|Rx-only]] in US (1)

Showing below up to 3 results in range #1 to #3.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

1

2


View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"